Abstract
A machine learning–based model incorporating clinical, genetic, echocardiography, and cardiac MRI variables demonstrated good performance for major adverse cardiac event prediction in patients with hypertrophic cardiomyopathy.

This publication has 29 references indexed in Scilit: